世界卫生组织总干事谭德塞与英国卫生大臣Steve Barclay在伦敦举行首次一对一会议，就全球卫生优先事项进行战略对话1。会议期间，双方围绕大流行病防治国际协议、乌克兰支持和抗菌素耐药性等议题进行了深入讨论1。
英国政府在此次会议中着重强调了加快数据共享、公平获取疫苗和治疗、以及加强科研合作的重要性1。作为具体行动，英国宣布为抗感染新药研究投入3900万英镑1。英国卫生大臣Steve Barclay表示，"英国在应对包括抗菌素耐药性在内的全球最严峻卫生威胁中发挥着主导作用"1。
谭德塞对此次合作表示高度肯定，指出与卫生大臣以及国际发展大臣和卫生大臣的战略对话充分表明了英国对全球公共卫生的承诺1。英国国际发展大臣Andrew Mitchell和卫生大臣Will Quince参与了年度英国-WHO战略对话1。2022年及前一个两年期内，英国是WHO核心自愿捐助账户的最大贡献者1。
World Health Organization Director-General Tedros Adhanom Ghebreyesus held his first one-on-one meeting with UK Health Secretary Steve Barclay in London on Tuesday, focusing on international agreements for pandemic prevention, support for Ukraine, and antimicrobial resistance as key global health priorities 1. The discussions underscored the strengthening collaboration between the two entities in addressing critical health threats facing the world.
The UK government emphasized the urgency of accelerating data sharing, ensuring equitable access to vaccines and treatments, and bolstering research collaboration 1. The government announced a commitment of £39 million toward research into new antimicrobial drugs, reflecting its determination to tackle antimicrobial resistance 1. Barclay stated that "The UK is playing a leading role in tackling some of the world's greatest health threats, including antimicrobial resistance" 1. The UK had been the largest contributor to WHO's core voluntary contributions account in 2022 and the preceding two-year period 1.
Tedros praised the partnership, remarking that "Today's strategic dialogue with Ministers Mitchell and Quince, and my productive discussions with Secretary of State Barclay, demonstrated the UK's commitment to global public health" 1. The meeting was part of the annual UK-WHO strategic dialogue, which also included International Development Minister Andrew Mitchell and Health Minister Will Quince 1.
评论
还没有评论，欢迎留下第一条。